La Jolla Institute for Allergy and Immunology, La Jolla, CA, United States.
Division of Clinical Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Front Immunol. 2018 Feb 13;9:235. doi: 10.3389/fimmu.2018.00235. eCollection 2018.
Mouse allergy has become increasingly common, mainly affecting laboratory workers and inner-city households. To date, only one major allergen, namely Mus m 1, has been described. We sought to identify T cell targets in mouse allergic patients. PBMC from allergic donors were expanded with either murine urine or epithelial extract and subsequently screened for cytokine production (IL-5 and IFNγ) in response to overlapping peptides spanning the entire Mus m 1 sequence, peptides from various Mus m 1 isoforms [major urinary proteins (MUPs)], peptides from mouse orthologs of known allergens from other mammalian species and peptides from proteins identified by immunoproteomic analysis of IgE/IgG immunoblots of mouse urine and epithelial extracts. This approach let to the identification of 106 non-redundant T cell epitopes derived from 35 antigens. Three major T cell-activating regions were defined in Mus m 1 alone. Moreover, our data show that immunodominant epitopes were largely shared between Mus m 1 and other MUPs even from different species, suggesting that sequence conservation in different allergens is a determinant for immunodominance. We further identified several novel mouse T cell antigens based on their homology to known mammalian allergens. Analysis of cohort-specific T cell responses revealed that rhinitis and asthmatic patients recognized different epitope repertoires. Epitopes defined herein can be formulated into an epitope "megapool" used to diagnose mouse allergy and study mouse-specific T cell responses directly . This analysis of T cell epitopes provides a good basis for future studies to increase our understanding of the immunopathology associated with MO-allergy and asthma.
小鼠过敏已变得越来越常见,主要影响实验室工作人员和城市内部家庭。迄今为止,仅描述了一种主要过敏原,即 Mus m 1。我们试图确定小鼠过敏患者中的 T 细胞靶标。用鼠尿或上皮提取物扩增过敏供体的 PBMC,然后针对跨越 Mus m 1 序列全长的重叠肽、来自各种 Mus m 1 同工型的肽[主要尿蛋白 (MUP)]、来自其他哺乳动物物种的已知过敏原的鼠同源物的肽以及通过免疫印迹免疫球蛋白 E/免疫球蛋白 G 的免疫蛋白质组分析鉴定的蛋白质的肽筛选细胞因子产生(IL-5 和 IFNγ)。这种方法鉴定了来自 35 种抗原的 106 个非冗余 T 细胞表位。仅在 Mus m 1 中定义了 3 个主要的 T 细胞激活区域。此外,我们的数据表明,免疫显性表位在 Mus m 1 和其他 MUP 之间(即使来自不同物种)也很大程度上共享,这表明不同过敏原中的序列保守性是免疫显性的决定因素。我们还根据与已知哺乳动物过敏原的同源性,基于几个新的小鼠 T 细胞抗原。对队列特异性 T 细胞反应的分析表明,鼻炎和哮喘患者识别不同的表位库。本文定义的表位可以制成一个表位“大池”,用于诊断小鼠过敏并直接研究小鼠特异性 T 细胞反应。对 T 细胞表位的这种分析为进一步研究提供了良好的基础,以增加我们对与 MO-过敏和哮喘相关的免疫病理学的理解。